Join the movement at Digital Health 2023, May 16-17 in San Diego, California. Revive healthcare by empowering clinicians, engaging patients, and embracing digital solutions. Collaborate with 300+ leaders for transformative insights, learning, and networking. Together, let's drive disruptive change, streamline workflows, cut costs, and prioritize consumer-oriented care. Be part of the solution at Reuters Events: Digital Health USA 2023.

Read on events.reutersevents

Each virtual workshop offers a deep dive into relevant issues related to clinical quality. Participate in a unique interactive virtual experience resulting in actionable items that can be immediately applied to your organization to improve clinical quality and drive a quality culture.

Read on go.evvnt.com

The Bio-IT World Conference & Expo is the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. For over 20 years, the Event has united a community of leading life sciences, pharmaceutical, clinical, healthcare, informatics, and technology experts in the fields of biomedical research, drug discovery & development, and healthcare from around the world.

Read on cii.dryfta.com

Like most other RCM leaders in healthcare right now, you're trying (and expected) to get more done with fewer staff and resources while simultaneously meeting patients' expectations for flexible, digital payments. To pull off this balancing act and boost revenue recovery, leaders from top health organizations are turning to automation. In this live webinar, RCM experts will share how automation platforms can improve the practices and operations of your accounts receivables strategies. 

Tune in for actionable tips on: 

• Using automation tools to improve effective protocols within your existing workflow
• Optimizing account presentation to reduce denials and enhance insurance follow-up
• Accelerating reimbursement through efficient, automated data-exchange processes
• Augmenting self-pay strategies with other data sources and using a tech-based approach to account segmentation and propensity to pay

Read on go.beckershospitalreview.com

The Accelerating Health Equity Conference brings together professionals focused on improving community and population health and building partnerships, as well as those striving to advance diversity and inclusion within hospital management and executive levels. They will focus on how to address systemic inequities that prevent individuals and their communities from achieving optimal health. Long-standing health care disparities and inequities have been illuminated and exacerbated by the COVID-19 pandemic. Systemic inequities, such as structural racism and economic disadvantages within diverse communities, are preventing individuals – and their communities - from achieving optimal health, leading to avoidable differences in health outcomes.

Read on aha.org

Following the excitement behind President Biden signing the FDA modernization Act 2.0 in December 2022, Hesperos and Sanofi successfully getting IND approval from organ-on-chip data for a Phase2 clinical trial, and NIH bioprinting eye tissue to develop in vitro models of AMD, the , the 8th Annual 3D Tissue Models Summit will return to Boston in May 2023 to reunite the community of drug discovery and development experts. This is the definitive meeting for drug developers to explore and integrate complex 3D models featuring 24+ real-life case studies across 2 dedicated tracks and their lessons learned.

Read on go.evvnt.com

The 2nd Next Generation RNA Therapeutics Summit returns as the first and only industry-dedicated forum solely focused on next generation RNA therapeutics and vaccines that are more targeted, and efficacious, with reduced off targets than first generation RNA therapies to accelerate their therapeutic and commercial potential.

Expect exclusive data from KOLs on the most recent developments in circRNAs, saRNAs, eRNAs and tRNAs therapies.

Join 100+ thought leaders from the likes of Pfizer, Orna Therapeutics, Laronde, Replicate Bioscience and BioNTech to stay ahead of the curve and maximize the full therapeutic potential of next generation RNA modalities to gain clinical proof concept and reach patients in need.

Read on rna.com

Following the approval of Amylyx's Relyvrio in the US and Canada and further FDA decisions on the horizon in 2023, the ALS drug development landscape is gaining momentum and positivity. With booming pharma investment and new biotechs entering the field, there are still crucial translational challenges to address to bridge the gap and see clinical success for the wider ALS patient population.

Returning to Boston, the timely 2nd Annual ALS Drug Development Summit is the only industry-focused conference dedicated to overcoming preclinical and clinical challenges currently facing ALS pipelines. This is your must-attend meeting showcasing the latest breakthroughs in ALS in 2022 and 2023.

Read on go.evvnt.com

Following the success of the 2nd Annual Psychedelic Therapeutics and Drug Development Conference in 2022, we're thrilled to be hosting the 3rd Annual event on May 15-16, 2023 in Washington, DC. This event has been organized to bring together the world's leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

Our speakers and panelists will be covering important topics such as Clinical Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science, and New Clinical Data among other topics. This event has been designed and curated for the benefit of key stakeholders in this burgeoning area and will provide practical guidance, discussion and networking.

Read on go.evvnt.com

PEGS Boston Summit is recognized as the leading international meeting place for the biotherapeutics community. covering a wide spectrum of biologic drug development.

Experience the Future of Biotherapeutic Drug Development Welcome to PEGS Boston The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more. Harness the power of in-person events, form genuine connections, create valuable relationships with peers, and become part of the PEGS community.

Read on cii.dryfta.com